LOS ANGELES – (March 21, 2013) – The American Society for Andrology (ASA) is presenting its highest honor, The Distinguished Andrologist Award for 2013, to Christina Wang, MD, a Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) lead researcher who specializes in the study of male reproductive health and disease, it was announced today.
The organization dedicated to the study of male reproduction will present the award to Dr. Wang during its annual meeting April 13 in San Antonio, TX.
In notifying Dr. Wang of the award, the ASA said she has been on the "front line of andrology in both national and international circles for many years" and had "demonstrated outstanding skills as physician caring for patients with reproductive diseases."
It also noted that Dr. Wang has served as "a role model and mentor for a generation of students, residents and fellows," exhibited leadership by serving in key roles in many professional organizations and led basic and clinical research studies on androgen replacement therapy, hormonal male contraceptive development, diet and androgen metabolism, aging in men and environmental effects on sperm quality that are considered milestone investigations.
ASA, which was founded in 1975 to promote scientific interchange and knowledge of the male reproductive system, said Dr. Wang's research made her a "world leader" in the field.
"Congratulations to Dr. Wang for another well-deserved honor in her stellar career as a tireless researcher, physician, mentor, advocate and administrator," said David I. Meyer, PhD, LA BioMed president and CEO. "She has been incredibly productive, publishing more than 280 peer-reviewed articles and 67 book chapters. LA BioMed is a very proud beneficiary of her energy and her dedication."
Dr. Wang joined LA BioMed in 1993 and currently serves as the associate director of the UCLA-Clinical and Translational Science Institute. She also is a professor of medicine and assistant dean of clinical and translational sciences at the David Geffen School of Medicine at UCLA.
She has served as the World Health Organization's (WHO) chairperson of the Task Force on Methods for the Regulation of Male Fertility and as chair and member of the expert group that edited the last three editions of the WHO Laboratory Manual on semen analyses. She also served as special consultant for the United Nations (UN) for the UN Family Planning Association to review candidate centers, foster high quality research and monitor progress in developing countries.
Dr. Wang has served in various capacities in ASA since 1992, including vice president and president. She also served in various capacities in the International Society of Andrology, including as president from 2009-2013.
In addition, she has served as associate editor of the International Journal of Andrology and on the editorial board of the Journal of Andrology and the Journal of Clinical Endocrinology and Metabolism. Dr. Wang has been invited to give more than 100 lectures worldwide and she has been recognized by her colleagues and institutions with numerous awards, including the ASA Distinguished Service award in 2011.
About LA BioMed
Founded in 1952, LA BioMed is one of the country's leading nonprofit independent biomedical research institutes. It has approximately 100 principal researchers conducting studies into improved treatments and cures for cancer, inherited diseases, infectious diseases, illnesses caused by environmental factors and more. It also educates young scientists and provides community services, including prenatal counseling and childhood nutrition programs. LA BioMed is academically affiliated with the David Geffen School of Medicine at UCLA and located on the campus of Harbor-UCLA Medical Center. For more information, please visit http://www.LABioMed.org
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.